Skip to main content
Journal of Immunology Research logoLink to Journal of Immunology Research
. 2018 Mar 22;2018:6343608. doi: 10.1155/2018/6343608

Corrigendum to “The Role of Costimulation Blockade in Solid Organ and Islet Xenotransplantation”

Kannan P Samy 1, James R Butler 1, Ping Li 1, David K C Cooper 2, Burcin Ekser 1,
PMCID: PMC5885337  PMID: 29767012

In the article titled “The Role of Costimulation Blockade in Solid Organ and Islet Xenotransplantation” [1], there was an error in Figure 1 and its legend. The corrected figure is shown below.

Figure 1.

Figure 1

Costimulation pathways in T cell regulation. Upon MHC-antigen interaction with the TCR, costimulation pathways can augment or suppress the activation of the T cell. From left to right, CD28 is activated by CD80/CD86. CTLA-4 coinhibitor competes with CD28 for binding to CD80/CD86. CTLA-4Ig and belatacept work by taking advantage of their higher affinity to CD28 over CD80/CD86 and thereby block CD80/CD86 activation of CD28. CD154 and CD40 are other potent activators of T cells; monoclonal antibodies against either of these surface proteins have potential for application in transplant immunosuppression. PD-1 is expressed on T cells, and interaction with PD-1 ligand (PD-L1) produces a suppressive signal to the T cell.

References

  • 1.Samy K. P., Butler J. R., Li P., DKC C., Ekser B. The role of costimulation blockade in solid organ and islet xenotransplantation. Journal of Immunology Research. 2017;2017:11. doi: 10.1155/2017/8415205.8415205 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Immunology Research are provided here courtesy of Wiley

RESOURCES